The mechanisms by which pulmonary surfactant protein B (SP-B) affects the surface activity of surfactant lipids are unclear. We have studied the peptide/lipid interactions of the amino-terminal amphipathic domain of SP-B by comparing the secondary conformations and surface activities of a family of synthetic peptides based on the native human SP-B sequence, modified by site-specific amino acid substitutions. Circular dichroism measurements show an ahelical structure correlating with the ability of the peptides to interact with lipids and with the surface activity of peptide/lipid dispersions. Amino acid substitutions altering either the charge or the hydrophobicity of the residues lowered the helical content and reduced the association of the aminoterminal segment with lipid dispersions. Surface activity of peptide/lipid mixtures was maximally altered by reversal of charge in synthetic peptides. These observations indicate that electrostatic interactions and hydrophobicity are important factors in determining optimal structure and function of surfactant peptides in lipid dispersions.
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Surfactant protein B (SP-B, Mr 9000; refs. 1 and 2) is encoded on chromosome 2 and synthesized by type 2 pneumocytes (3-6). The primary translation product for SP-B is a 381-residue glycosylated preprotein (Mr 42,000) (7) . Amino-and carboxyl-terminal proteolytic cleavage produces a 79-residue peptide, with amino terminus located at residue 201 of the preprotein. Mature SP-B lacks glycosylation sites, is highly hydrophobic, and has a basic pl. In contrast to surfactant protein C (SP-C), SP-B has no covalently linked lipids, although it coisolates with SP-C and surfactant lipids (8) . Four of 10 positively charged residues (two arginines, two lysines) appear at the amino terminus. Negatively and positively charged residues are found at the carboxyl terminus (one aspartate, one glutamate, four arginines). Intra-and intermolecular sulfhydryl bonds are important structural features of the mature protein, which contains seven cysteines and is oligomeric under oxidizing conditions (9, 10) .
Together with surfactant protein A (SP-A) and SP-C, SP-B interacts with lipids to form mammalian pulmonary surfactant. SP-B is present in lamellar bodies in type II pneumocytes and appears in bronchoalveolar lavage. SP-B from bovine and porcine sources contributes to the function of surfactant preparations used in replacement therapies (11) (12) (13) (14) (15) . Synthetic SP-B (16) and synthetic peptides from predicted amphipathic sequences of human SP-B (17) emulate native SP-B in surfactant lipid dispersions (13, (16) (17) (18) (19) .
Quantitative measurements of the amphipathicity of the human amino acid sequence of SP-B using the Eisenberg hydrophobic algorithm (20) predict that the amino-terminal sequence has a high a hydrophobic moment (9, 21) . Therefore, we investigated the amino-terminal sequence of SP-B to identify secondary structures and specific conformations associated with surface activity in peptide/lipid dispersions.
Based on the native amino-terminal human sequence of SP-B, a 25-amino acid peptide was synthesized, B(1-25) (Table 1 ). This sequence was modified by specific amino acid substitutions to obtain five additional peptides. These synthetic B analogs were compared to investigate the role of individual residues in protein structure and function. We hypothesized that charge, hydrophobicity, size, and potential for oligomerization would impose constraints on the threedimensional peptide conformation in the different solvating environments used in the study, thereby affecting peptide interaction with surfactant lipids (22) .
MATERIALS AND METHODS
Rationale for Amino Acid Substitutions. Synthetic analog peptides of B are defined in Table 1. Cysteines 8 and 11 were replaced with alanine residues, to prevent disulfidedependent oligomerization (A/C). Seven hydrophobic leucine and isoleucine residues were substituted by alanine throughout B , thereby decreasing the hydrophobicity of the sequence (A/L-I). Specific effects of polar residues were tested by three different substitutions. Arginines in positions 12 and 17 were replaced with lysines, retaining the charge but substituting the guanidinium ring with an aliphatic chain, to reduce the steric hindrance of the residue (K/R). Amphipathicity of the sequence was altered by substituting polar, charged lysines (positions 16 and 24) and arginines (positions 12 and 17) with polar, uncharged serine (S/K-R). The net positive charge of the sequence was reversed by introducing glutamate in positions 12, 16, 17, and 24 (E/K-R).
Secondary structure was predicted by the Chou-Fasman algorithm (23) , the Schiffer-Edmundson a-helical wheel (24) , and the Eisenberg hydrophobic moment plot (20) .
Peptide Synthesis and Purification. B(1-25) analogs were synthesized using the solid-phase method of Merrifield, employing a tert-butyloxycarbonyl strategy (UCLA Peptide Synthesis Facility) as described (17, 25) . Peptides were purified by reverse-phase HPLC using a water/acetonitrile/0.1% trifluoroacetic acid mixture on a Vydac C4 preparative column. Purified fractions were dried by vacuum centrifugation and the molecular weight of each peptide was confirmed by fast atom bombardment mass spectroscopy (City of Hope, Mass Spectroscopic Facility, Duarte, CA).
Preparation of Lipid/Peptide Dispersions. Phospholipids were from Avanti Polar Lipids; palmitic acid was from 
The amino-terminal human sequence of SP-B (7), given in threeletter code, is as follows: NH2-Phe-Pro-Ile-Pro-Leu-Pro-Tyr-CysTrp-Leu-Cys-Arg-Ala-Leu-Ile-Lys-Arg-Ile-Gln-Ala-Met-Ile-ProLys-Gly-COOH.
Nu-Chek-Prep (Elysian, MN); solvents were HPLC grade or higher. The standard lipid mixture contained dipalmitoyl phosphatidylcholine (DPPC), egg phosphatidyl glycerol (PG), and palmitic acid (PA), 68:22:9 (wt/wt). These lipids have been employed in several reconstitution studies and are referred to as Tanaka lipids (9, 17, 26 an aqueous solution of (+)-10-camphorsulfonic acid (1 mg/ ml) in a 1-mm path length cell (27) . Samples were scanned from 250 nm to 195 nm, scan rate of 10 nm per minute. Four to eight spectra were averaged, baseline corrected, smoothed, and analyzed for relative a-helical content by unrestrained least-squares-fit algorithm (28) , based on polylysine reference spectra (29) .
TR spectra were recorded with a Nicolet 205 FTIR spectrophotometer. The peptide/lipid dispersions were dried onto a zinc selenide attenuated total reflectance crystal (SpectraTech, Stamford, CT) to produce multilayers as described by Rafalski et al. (30) . Spectra were averaged from 128 scans at a gain of 4 and a spectral resolution of 4 cm- Surface Tension Measurements of Peptide/Lipid Interaction. Adsorption and spreading of peptide/lipid dispersions, 2.4 mg/ml, were similarly studied in a King-Clements device. Estimates of adsorption were assessed by injecting 0.5-mI samples of peptide/lipid mixtures in 30 ml of saline (37°C, pH 5.3). Surface spreading was evaluated by loading 10-,ul samples on the surface. Changes in surface tension were recorded for 120 sec, during which time >95% of the change in surface tension takes place.
Measurements of change in surface tension of peptide/lipid mixtures during compression were carried out at 37°C on unbuffered saline, in a modified Langmuir-Wilhelmy surface balance (KimRay, Greenfield Surfactometer, Oklahoma City, OK). Ten-microliter samples were loaded on a 51.5-cm2 rectangular Teflon trough. Five 90-sec compression cycles of the surface film by 85% of the total area were carried out. Data were collected from the fifth run. Maximum and minimum surface tensions and the fraction of the total area at which surface tension fell below 10 mN/n (% area c 10 mN/in), corresponding to the length of the collapse plateau, were used for comparison of the various dispersions.
RESULTS AND DISCUSSION
Chou-Fasman analysis of the first 25 residues of the human SP-B sequence suggested a high probability of a-helical conformation for residues 10-22. Residues 15-25 had a high a moment and fell in the surface sector of the hydrophobic moment plot (21) . Further examination of the amino-terminal domain using a Schiffer-Edmundson analysis (Fig. 1) showed segregation of polar residues from nonpolar ones in two distinct hemifaces, typifying amphipathic sequences (37) .
Site-specific amino acid substitutions altered positioning of two synthetic peptides on the hydrophobic moment plot (Fig.   2 ). In the A/L-I sequence, the hydrophobicity and the hydrophobic moment decreased, thus moving this peptide to (Table 3) . TFE/PBS solutions were used to test the tendency to express a-helical structures and to assess the sensitivity of this structure to changes in solvent polarity, in a helixpromoting solvent system (38) . At 25% TFE/PBS, all peptides showed low helical content. Sequences with more hydrophilic residues (A/L-I) or a charge reversal (E/K-R) showed the lowest degree of a-helical structure in this relatively polar solvent system. Increasing TFE to 50% enhanced the helix content of B(1-25) and ofthe analogs. The CD spectra in TFE/PBS (1:1) were the same at pH 4.0, 5.3, and 7.0, suggesting that, within this pH range, the peptide conformation is stable. In this solvent system all peptides had a dominant a-helical structure, indicating that these sequences assume an a-helical configuration in specific environments.
To evaluate peptide conformations at a membranemimicking interface, CD spectroscopy was carried out using SDS micelles (30) . All of the peptides adopted a dominant a-helical component. These results suggest that B(1-25) and the analogs preferentially assume helical conformations in an anionic micellar environment. CD measurements of synthetic SP-B peptides in Tanaka lipid dispersions showed environment-dependent secondary structure. CD spectra for B and A/L-I are shown in Fig. 3. B(1-25) , A/C, and K/R all had high helical contents, as observed in 50% TFE/PBS and SDS micelles. S/K-R had a slightly lower helical content than B , and E/K-R and A/L-I had significantly lower helical content in lipid dispersions. After sedimentation of A/L-I by ultracentrifuge (60 min, 100,000 x g) the supernatant had the same CD spectra as the peptide/lipid dispersions, characterized by a largely disordered conformation. These findings confirmed that A/L-I preferentially associates with more polar environments, rather than with lipids. On the other hand, E/K-R associated with the lipids but had a decreased helical content, suggesting that peptide folding in anionic lipid was also dependent on peptide charge. Therefore, the a-helical con- tent of the amphipathic segment in lipids appears to be dependent on charge and hydrophobicity of residues.
Since peptide/lipid interactions may alter light scattering of lipid vesicles, thereby affecting CD measurements, we used FTIR spectroscopy to complement the CD studies. FTIR measurements of B Surface tension values are at 10 and 120 sec. Hypophase as in Table 4 . Surface area, 44.2 cm2. Adsorption: lipid concentration, 40 ,ug/ml; mean ± SD, 5-13 determinations. Spreading: lipid load, 24 jug; mean ± SD, 5-16 determinations. (Fig. 4) . S/K-R and E/K-R had a lower ir, than B(1-25). E/K-R had a slightly higher vc, when tested against a monolayer of DPPC:SA:PA, presumably because SA introduces positive charges in the monolayer. These observations support the hypothesis that electrostatic interactions between lipid head groups and peptide residues influence the insertion of an amphipathic helix in a lipid structure.
Dispersions containing S/K-R and E/K-R showed significantly different rates of adsorption and spreading, compared to B(1-25) (P < 0.05, by t test) ( Table 5 ), indicating that peptides that interact poorly with anionic lipids are less effective in enhancing adsorption and spreading of peptide/ lipid dispersions.
Under compression, S/K-R and E/K-R had a signifcantly shorter collapse plateau than other dispersions (P < 0.05, by t test), as shown in Table 6 . These results are consistent with those obtained by measures of spreading, adsorption, and insertion. The collapse plateau for S/K-R manifested a wide variability (standard deviation of 50%6), suggesting that this peptide/lipid dispersion constitutes nonhomogeneous populations of vesicles with different degrees of peptide/lipid affiliation.
We anticipated that the A/L-I peptide, with decreased hydrophobic moment, a-helical conformation, and affinity for lipids, would have decreased surface activity in peptide/ lipid mixtures. Contrary to this expectation, adsorption rates and degree of surface compression to achieve low surface tension were similar to those found with B(1-25). We hypothesize that A/L-I affiliates with a lipid monolayer predominantly by means of electrostatic interactions, whereas other peptides bind to surface lipids by hydrophobic and electrostatic interactions. Peptide/lipid charge associations may therefore have more importance for peptide/lipid interaction and surface activity than degree of hydrophobicity, amphipathicity, or conformation.
In summary, the present investigation illustrates the role of individual residues in the interaction of B(1-25) with surfactant lipids. Behavior of B in lipid dispersions mainly depends on electrostatic interactions and on hydrophobicity. Shape of residues and capacity for oligomerization by means of sulfhydryl links are less important. Inter-and intramolecular disulfide bond formation in the intact SP-B protein may also impose specific conformational constraints on other protein domains and have important effects on function. Study of full-length SP-B in oxidized and reduced forms is required to further define the role of oligomeric SP-B, the form of native SP-B, in surfactant lipids.
